Zobrazeno 1 - 2
of 2
pro vyhledávání: '"C Del Moral Alcazar"'
Autor:
M Merino Almazan, MJ Barbero Hernandez, R Millan Garcia, T Vilchez Medina, F Horno Ureña, M Barrales Iglesias, A Sánchez Ruiz, C Del Moral Alcazar, R Saldaña Soria, T Moreno Diaz
Publikováno v:
European Journal of Hospital Pharmacy. 23:A66.3-A67
Background Several new drugs for the treatment of hepatitis C virus (HCV) have been released in the past years. Clinical trials have demonstrated good efficacy. These clinical trials of regimens to treat chronic infection with HCV used as their prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a06be42432ac57a011eaa18486aedb02
https://doi.org/10.1136/ejhpharm-2016-000875.151
https://doi.org/10.1136/ejhpharm-2016-000875.151
Autor:
MJ Barbero Hernandez, Cantudo Cuenca, R Cantudo Cuenca, MB Dominguez Aguado, C Del Moral Alcazar, F Horno Ureña, R Saldaña Soria, M Vargas Lorenzo, A Acuña Vega
Publikováno v:
European Journal of Hospital Pharmacy. 20:A117.1-A117
Background Tolvaptan is the first oral antagonist of the vasopressin V2 receptor. It is indicated in adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH). Purpose To evaluate the use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f074da92f2f15f135b78fe804db1ea7
https://doi.org/10.1136/ejhpharm-2013-000276.324
https://doi.org/10.1136/ejhpharm-2013-000276.324